Federated Hermes, Inc. Opiant Pharmaceuticals, Inc. Transaction History

Federated Hermes, Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 13, 2022	SELL	$19.54 - $33.59 $1,231 - $2,116	-63 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$13.28 - $25.79 $836 - $1,624	63 New	63 $2,000
Q1 2021 May 13, 2021	SELL	$8.2 - $14.49 $2,492 - $4,404	-304 Closed	0 $0
Q4 2020 Feb 12, 2021	BUY	$6.87 - $8.88 $384 - $497	56 Added 22.58%	304 $2,000
Q2 2020 Aug 13, 2020	BUY	$8.64 - $11.87 $2,142 - $2,943	248 New	248 $2,000

300

Ticker OPNT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 5,164,150
Description
Opiant Pharmaceuticals, Inc., a specialty pharmaceutical company, develops medicines for addictions and drug overdose. The company offers NARCAN nasal spray, a treatment to reverse opioid overdoses. Its pipeline of product candidates includes medicines for the treatment for opioid overdose reversal; alcohol use disorders; acute cannabinoid overd...

Get notified when there are updates to the investment portfolio of Federated Hermes, Inc., based on Form 13F filings with the SEC.

Stay updated on Federated Hermes, Inc. with notifications on news.